Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davis R Ingram

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 19, 2016
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survivalArjen H G Cleven, Ghadah A Al Sannaa, Inge Briaire-de Bruijn, et al.
BMC Cancer|November 18, 2015
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomasCaitlin D May, Jeannine Garnett, XiaoYan Ma, et al.
Cancer Cell|June 5, 2018
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial SarcomaMatthew J McBride, John L Pulice, Hannah C Beird, et al.
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical ValidationSandra L Grimm, Menuka Karki, Kyle A Blum, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell StatesRyan A Denu, Zhao Zheng, Yingda Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary CarcinomaKai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Cell Reports. Medicine|October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profilingPavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Cell Reports|October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Nature Communications|June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcomaSalah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 19, 2016
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survivalArjen H G Cleven, Ghadah A Al Sannaa, Inge Briaire-de Bruijn, et al.
BMC Cancer|November 18, 2015
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomasCaitlin D May, Jeannine Garnett, XiaoYan Ma, et al.
Cancer Cell|June 5, 2018
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial SarcomaMatthew J McBride, John L Pulice, Hannah C Beird, et al.
Molecular Cancer Therapeutics|April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient LeiomyosarcomasMichael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical ValidationSandra L Grimm, Menuka Karki, Kyle A Blum, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell StatesRyan A Denu, Zhao Zheng, Yingda Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary CarcinomaKai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Cell Reports. Medicine|October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profilingPavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Cell Reports|October 21, 2020
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Emily Z Keung, Ming Tang, et al.
Nature Communications|June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcomaSalah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
Pageof 6